Home › Ulcerative Colitis › North Carolina
Ulcerative Colitis clinical trials in North Carolina
21 studies for Ulcerative Colitis are looking for participants at sites in North Carolina.
Cities in North Carolina
- Durham8 studies
- Charlotte6 studies
- Wilmington4 studies
- Fayetteville4 studies
- Greenville3 studies
- Raleigh3 studies
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Atrium Health Gastroenterology and Hepatology, Charlotte
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 12, 2026 · NCT06636656LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Carolina Digestive Diseases and Endoscopy Center, Greenville
- Wilmington Health, PLLC, Wilmington
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 4, 2026 · NCT07415044Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Coastal Research Institute - Fayetteville, Fayetteville
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Nov 4, 2026 · NCT06937086A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- University of North Carolina at Chapel Hill, Chapel Hill
RecruitingPhase 4
Ages 18 and older · Women · Updated Nov 3, 2026 · NCT07654751A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- University of North Carolina Hospital, Chapel Hill
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07577856Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Raleigh
RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Oct 30, 2026 · NCT06619990A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Charlotte Gastroenterology and Hepatology, P.L.L.C, Charlotte
- Carolina Digestive Diseases, Greenville
- Piedmont Healthcare, Statesville
- and 1 more
RecruitingPhase 4
Ages 18 to 80 · All sexes · Updated Oct 28, 2026 · NCT06581328A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Monroe Biomedical Research, Monroe
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT06979336Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Digestive Health Partners /ID# 280490, Asheville
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 27, 2026 · NCT07697456A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- 040, Chapel Hill
- Site 041, Durham
- Site 016, Winston-Salem
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 27, 2026 · NCT07012395An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill
- OnSite Clinical Solutions, LLC, Charlotte
RecruitingObservational study
Ages 18 to 64 · All sexes · Updated Oct 26, 2026 · NCT06398626An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- UNC Hospitals, The University of North Carolina at Chapel Hill - Site Number: 8400074, Chapel Hill
- OnSite Clinical Solutions - Site Number: 8400051, Charlotte
- Duke University Medical Center - Site Number: 8400093, Durham
- and 3 more
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Oct 23, 2026 · NCT07184996Confirmatory Clinical Study in Active Ulcerative Colitis
- Cross Creek Medical Clinic, Fayetteville
- Peters Medical Research, High Point
RecruitingPhase 2
Ages 16 and older · All sexes · Updated Oct 21, 2026 · NCT07296315A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Cross Creek Medical Clinic - Site Number: 8400057, Fayetteville
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Oct 16, 2026 · NCT07185009Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- University of North Carolina, Chapel Hill
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 9, 2026 · NCT06750731BOOM-IBD2 Pivotal Clinical Trial
- UNC Chapel Hill, Chapel Hill
Recruiting
Ages 18 to 85 · All sexes · Updated Aug 6, 2026 · NCT06571669Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of North Carolina, Chapel Hill
- Atrium Health Center for Gastroenterology and Surgery, Charlotte
- Wake Forest School of Medicine, Winston-Salem
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT07237516A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
- PPD Virtual - PPD - US, Wilmington
RecruitingObservational study
All ages · Women · Updated Jun 15, 2026 · NCT05953402A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, High Point
- Mirador Therapeutics Selected Site, Raleigh
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Mar 12, 2026 · NCT07113522Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
- Bausch Health Site 010, Greenville
RecruitingPhase 4
Ages 5 to 17 · All sexes · Updated Sep 16, 2025 · NCT04314375IBD Pregnancy Registry
- PPD, Wilmington
RecruitingObservational study
Ages 18 to 50 · Women · Updated Apr 4, 2025 · NCT06910553From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.